Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Pakistan: Health department begins probing two death as deague cases rise
- WHO report shows one in six bacterial infections globally are resistant to standard antibiotics. Why is the situation alarming?
- Maldives becomes world's first nation to eliminate mother-to-child transmission of hepatitis B
- WHO report: 1 in 10 healthcare workers in Europe battling suicidal thoughts
- Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi win Nobel Prize in Medicine. What did they discover?
